BB Healthcare Trust PLC Issue of Equity (9764U)

TIDMBBH

RNS Number : 9764U

BB Healthcare Trust PLC

03 August 2020

 
 3 August 2020 
 
   NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, 
   TO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH 
   AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN THE 
   UNITED KINGDOM) OR TO ANY NATIONAL, RESIDENT OR CITIZEN OF 
   THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH 
   AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN THE 
   UNITED KINGDOM OR TO PROFESSIONAL INVESTORS IN IRELAND) 
 
                         BB Healthcare Trust plc 
 
                        Issue of Ordinary Shares 
 
 BB Healthcare Trust plc (the "Company") announces that it has 
  today issued 725,000 of its ordinary shares of one penny each 
  ("Ordinary Shares") pursuant to its block listing facility. 
  The Ordinary Shares will be issued at a price of 157.00 pence 
  per Ordinary Share, a premium to the prevailing net asset value 
  ("cum income") per Ordinary Share. 
 
 Following the issue of Ordinary Shares, the Company's issued 
  share capital will comprise (467,350,000) Ordinary Shares and 
  this is the total number of Ordinary Shares with voting rights 
  in the Company. This figure (467,350,000) may be used by shareholders 
  as the denominator for the calculations by which they will 
  determine if they are required to notify their interest in, 
  or a change to, their interest in the Company under the Financial 
  Conduct Authority's Disclosure Guidance and Transparency Rules. 
 
 The Company's LEI is: 213800HQ3J3H9YF2UI82 
 
 For further information please contact: 
 
 Peel Hunt LLP 
 Liz Yong, Tom Pocock (Corporate Broking) 
 Telephone: [phone] 
 
 J.P. Morgan Cazenove 
 James Bouverat (Sales) 
 Telephone: [phone] 
 
 Bellevue Asset Management (UK) Ltd 
 Mark Ghahramani 
 Telephone: [phone] 
 
 
 Disclaimer 
 
 This announcement does not constitute a prospectus relating 
  to the Company and does not constitute, or form part of, any 
  offer or invitation to sell or issue, or any solicitation of 
  any offer to purchase or subscribe for, any shares in the Company 
  in any jurisdiction nor shall it, or any part of it, or the 
  fact of its distribution, form the basis of, or be relied on 
  in connection with or act as any inducement to enter into, 
  any contract therefore. 
 
 Peel Hunt LLP ("Peel Hunt") and J.P. Morgan Cazenove, which 
  are authorised and regulated by the Financial Conduct Authority, 
  are acting for the Company only in connection with the matters 
  described in this announcement and are not acting for or advising 
  any other person, or treating any other person as their client, 
  in relation thereto and will not be responsible for providing 
  the regulatory protection afforded to clients of Peel Hunt 
  and J.P. Morgan Cazenove or advice to any other person in relation 
  to the matters contained herein. 
 
 The shares of the Company have not been and will not be registered 
  under the US Securities Act of 1933, and may not be offered 
  or sold in the United States absent registration or an applicable 
  exemption from the registration requirements. Moreover, the 
  shares of the Company have not been, nor will they be, registered 
  under the applicable securities laws of Australia, Canada, 
  the Republic of South Africa, Japan or any member state of 
  the EEA (other than the United Kingdom). Further, the Company 
  will not be registered under the US Investment Company Act 
  of 1940, as amended. Subject to certain exceptions, the shares 
  of the Company may not be offered or sold in the United States, 
  Australia, Canada, the Republic of South Africa, Japan or any 
  member state of the EEA (other than the United Kingdom or to 
  professional investors in Ireland) or to, or for the account 
  or benefit of, any national, resident or citizen of the United 
  States, Australia, Canada, the Republic of South Africa, Japan 
  or any member state of the EEA (other than the United Kingdom 
  or to professional investors in Ireland). The share issuance 
  programme, and the distribution of this announcement, in other 
  jurisdictions may be restricted by law and the persons into 
  whose possession this announcement comes should inform themselves 
  about, and observe, any such restrictions. 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

IOEFLFVETLIVIII

(END) Dow Jones Newswires

August 03, 2020 11:32 ET (15:32 GMT)